DOI: 10.1128/mBio.00873-13
Article Information
PubMed
Published By
History
- Received October 13, 2013
- Accepted October 15, 2013
- Published online November 19, 2013.
Copyright & Usage
Copyright © 2013 Smith et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Editors and / or Reviewers
- W. Ian Lipkin, Editor, Columbia University
Author Information
- Scott A. Smitha,b,
- A. Ruklanthi de Alwisc,
- Nurgun Koseb,
- Eva Harrisd,
- Kristie D. Ibarrad,
- Kristen M. Kahlee,
- Jennifer M. Pfaffe,
- Xiaoxiao Xiange,
- Benjamin J. Doranze,
- Aravinda M. de Silvac,
- S. Kyle Austinf,
- Soila Sukupolvi-Pettyf,
- Michael S. Diamondf,
- James E. Crowe, Jr.b,g,h
- Department of Medicine, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USAa
- The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USAb
- Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USAc
- Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, USAd
- Integral Molecular Inc., Philadelphia, Pennsylvania, USAe
- Departments of Medicine, Molecular Microbiology, Pathology, and Immunology, Washington University School of Medicine, St. Louis, Missouri, USAf
- Department of Pediatrics, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USAg
- Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee, USAh
- Address correspondence to James E. Crowe, Jr., james.crowe{at}vanderbilt.edu.
Citation Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE, Jr. 2013. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. mBio 4(6):e00873-13. doi:10.1128/mBio.00873-13.
